Two-stage resection of a bilateral pheochromocytoma and pancreatic neuroendocrine tumor in a patient with von Hippel-Lindau disease: A case report

Yutaka Endo; Minoru Kitago; Akira Miyajima; Isao Kurihara; Kaori Kameyama; Masahiro Shinoda; Hiroshi Yagi; Yuta Abe; Taizo Hibi; Chisato Takagi; Yutaka Nakano; Wataru Koizumi; Osamu Itano; Yuko Kitagawa

doi:10.1016/j.ijscr.2018.02.020

Two-stage resection of a bilateral pheochromocytoma and pancreatic neuroendocrine tumor in a patient with von Hippel-Lindau disease: A case report

Int J Surg Case Rep. 2018:44:139-142. doi: 10.1016/j.ijscr.2018.02.020. Epub 2018 Feb 16.

Authors

Affiliations

¹ Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
² Department of Surgery, Keio University School of Medicine, Tokyo, Japan. Electronic address: dragonpegasus@keio.jp.
³ Department of Urology, Tokai University School of Medicine, Kanagawa, Japan.
⁴ Department of Internal Medicine, Keio University of School of Medicine, Tokyo, Japan.
⁵ Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
⁶ Department of Gastrointestinal Surgery, International University of Health and Welfare, Chiba, Japan.

Abstract

Introduction: von Hippel-Lindau disease (vHL disease) is a hereditary disease in which tumors and cysts develop in many organs, in association with central nervous system hemangioblastomas, pheochromocytomas, and pancreatic tumors. We herein report a case of vHL disease (type 2A) associated with bilateral pheochromocytomas, pancreatic neuroendocrine tumors (PNET), and cerebellar hemangioblastomas treated via pancreatectomy after adrenalectomy.

Case presentation: A 51-year-old woman presented with a cerebellar tumor, bilateral hypernephroma, and pancreatic tumor detected during a medical checkup. 18F-fluorodeoxyglucose positron emission tomography-computed tomography revealed a bilateral adrenal gland tumor and a tumor in the head of the pancreas, while an abdominal computed tomography examination revealed a 30-mm tumor with strong enhancement in the head of the pancreas. Cranial magnetic resonance imaging showed a hemangioblastoma in the cerebellum. Therefore, a diagnosis of vHL disease (type 2A) was made. Her family medical history included renal cell carcinoma in her father and bilateral adrenal pheochromocytoma and spinal hemangioblastoma in her brother. A detailed examination of endocrine function showed that the adrenal mass was capable of producing catecholamine. Treatment of the pheochromocytoma was prioritized, and therefore, laparoscopic left adrenalectomy and subtotal resection of the right adrenal gland were performed. Once the postoperative steroid levels were replenished, subtotal stomach-preserving pancreatoduodenectomy was performed for the PNET. After a good postoperative course, the patient was discharged in remission on the 11th day following surgery. Histopathological examination findings indicated NET G2 (MIB-1 index 10-15%) pT3N0M0 Stage II A and microcystic serous cystadenoma throughout the resected specimen. The patient is scheduled to undergo treatment for the cerebellar hemangioblastoma.

Conclusion: A two-staged resection is a safe and effective treatment option for bilateral pheochromocytoma and PNET associated with vHL disease.

Keywords: Bilateral pheochromocytoma; Pancreatic neuroendocrine tumor; von Hippel-Lindau disease.